Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 59,000 CTMX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 59,000 | n/a |
| May 26, 2026 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 15,508 | n/a |
| Jun 13, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| May 29, 2025 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 4,600 | n/a |
| May 30, 2024 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 50,587 | n/a |
| May 17, 2024 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Mar 22, 2024 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 76,000 | n/a |
| Sep 1, 2023 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 68,000 | n/a |